Administration of low dose epoetin alfa facilitates adherence to ribavirin in triple therapy with PEG‐IFN‐alfa2b and telaprevir

ConclusionEPO can be a favorable alternative to reduction of RBV to facilitate the adherence of patients on TVR‐based triple therapy.

Source: Hepatology Research - August 19, 2013 Category: Internal Medicine Authors: Hisashi Ishida, Sadatsugu Sakane, Takashi Toyama, Keisuke Fukutomi, Keiichi Kimura, Aya Sugimoto, Kenji Hibino, Takeshi Tamura, Tetsuya Iwasaki, Ryuichiro Iwasaki, Hiroko Hasegawa, Yuko Sakakibara, Takuya Yamada, Shoichi Nakazuru, Eiji Mita Tags: Original Article Source Type: research